Clinical Study Administrator (CSA) Graduate Program jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 22 hours ago

Clinical Study Administrator (CSA) Graduate Program

AstraZeneca is a leading pharmaceutical company focused on innovative oncology medicines. The Clinical Study Administrator (CSA) Graduate Program offers a unique opportunity to work on clinical trials, providing insights into various aspects of study management and contributing to the development of life-changing treatments.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits

Responsibilities

Support teams in Trial Master File Administration (eTMF), Study Start-Up, and Site Monitoring
Make real contributions and work on projects supporting collection and filing of regulatory documents and study site activation
Develop skills in building and maintaining multi-disciplinary relationships
Receive mentoring and feedback from managers and colleagues

Qualification

Clinical trial processesRegulatory documentsLife science degreeTask managementMulti-disciplinary relationships

Required

Bachelor's degree awarded in 2025 or due to be awarded in 2026 in life science, health science, or related field
0 years of experience
Demonstrated ability to manage multiple priorities and meet deadlines in a fast-paced environment
Proven experience in planning, organizing, and tracking tasks to ensure timely completion of deliverables
Ability to travel throughout the US up to 50%

Preferred

Up to 2 years of prior work experience, including previous internships/co-ops
Understanding clinical trial processes and common regulatory documents, such as data collection, regulatory compliance, or patient interaction

Benefits

Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase